Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
48.52 EUR | +0.35% | +1.15% | +12.18% |
07-05 | Berenberg Adjusts Price Target on Corteva to $56 From $54, Maintains Hold Rating | MT |
06-25 | RBC Capital Adjusts Price Target on Corteva to $62 From $64 | MT |
Strengths
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- The company is in a robust financial situation considering its net cash and margin position.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- The company benefits from high valuations in earnings multiples.
- The company is not the most generous with respect to shareholders' compensation.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
Ratings chart - Surperformance
Sector: Agricultural Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+12.18% | 36.87B | - | ||
-.--% | 11.62B | - | B+ | |
+38.17% | 8.39B | - | C- | |
-7.91% | 7.25B | A | ||
+10.45% | 7.02B | B- | ||
-11.28% | 5.71B | B+ | ||
-11.78% | 5.38B | B | ||
+34.74% | 5.31B | B- | ||
-5.22% | 5.07B | C+ | ||
+6.45% | 3.97B | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- CTVA Stock
- 2X0 Stock
- Ratings Corteva, Inc.